Lecigon
Lecigon is a medicine authorised by Swissmedic under authorisation number 68360. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 February 2022 and the authorisation is valid without a time limit. ATC code N04BA03 places the medicine in the group Anti-Parkinson drugs.
| Authorisation number | 68360 |
|---|---|
| Name | Lecigon |
| Full name | Lecigon, Gel zur intestinalen Anwendung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N04BA03 |
| First authorisation | 02 February 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lecigon, Gel zur intestinalen Anwendung | B | 02 February 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 7 x 47 | ml | N04BA03 | 01.08.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lecigon authorised in Switzerland?
Yes. Lecigon is authorised by Swissmedic under authorisation number 68360, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lecigon have?
Lecigon is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lecigon?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.